Michael’s practice centers on protection, acquisition, evaluation and enforcement of intellectual property rights primarily in the biotechnology, pharmaceutical and medical device industries. He has extensive experience in a wide range of patent-related matters, including due diligence; litigation; client counselling; patent preparation and prosecution; post-grant proceedings; opinions on patent validity and infringement; and licensing. 

Trained in molecular and cell biology (B.S.), microbiology (M.S.), and human genetics (Ph.D.), he previously worked as a laboratory supervisor of the DNA Diagnostics Laboratory at Yale University School of Medicine. Michael uses his knowledge and training to assist clients in identifying valuable innovations for patenting, and obtaining and managing robust and enforceable patent protection in the United States and around the world.

In addition, Michael works with investment firms to evaluate intellectual property issues including strength of the target company’s patents and freedom-to-operate in view of third-party intellectual property. He also conducts intellectual property due diligence in the context of corporate mergers and acquisitions, technology transfer and licensing.